Expression of cGMP-binding cGMP-specific phosphodiesterase (PDE5) in mouse tissues and cell lines using an antibody against the enzyme amino-terminal domain

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1539, Issue 1-2, 2001, Pages 16-27

  Giordano, Daniela ^a   De Stefano, Maria Egle ^a   Citro, Gennaro ^b   Modica, Anna ^c   Giorgi, Mauro ^c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Cyclic guanosine monophosphate; Glutathione S transferase fusion protein; Murine neuroblastoma; Phosphodiesterase; Phosphodiesterase 5 antibody

Indexed keywords

BUCLADESINE; CYCLIC GMP; PHOSPHODIESTERASE; POLYCLONAL ANTIBODY; SILDENAFIL; ZAPRINAST;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; BRAIN; CEREBELLUM; CONTROLLED STUDY; ENZYME ACTIVITY; GLIOMA; HEART; IMMUNOPRECIPITATION; KIDNEY; LUNG; MOLECULAR RECOGNITION; MOLECULAR WEIGHT; MOUSE; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; PURKINJE CELL; RABBIT;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; ANIMALS; ANTIBODY SPECIFICITY; BLOTTING, WESTERN; BRAIN; IMMUNE SERA; IMMUNOHISTOCHEMISTRY; LIVER; LUNG; MICE; MYOCARDIUM; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PRECIPITIN TESTS; PURINONES; TISSUE EXTRACTS; TUMOR CELLS, CULTURED;

BOVINAE; MURINAE; ORYCTOLAGUS CUNICULUS;

EID: 0035962999     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4889(01)00086-6     Document Type: Article

References (41)

1. Cyclic nucleotide phosphodiesterases: Functional implications of multiple isoforms
2. Cyclic nucleotide phosphodiesterases: Gene complexity, regulation by phosphorylation, and physiological implications
3. Regulation of cAMP and cGMP signaling: New phosphodiesterases and new functions
4. Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A
5. Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A
6. Cloning and characterization of two splice variants of human phosphodiesterase 11A
7. Isolation and characterization of two novel phosphodiesterase PDE11A variants showing unique structure and tissue-specific expression
8. Signal flow in visual transduction
9. Mechanisms for activation of the rat adipocyte particulate cyclic-GMP-inhibited cyclic AMP phosphodiesterase and its importance in the antilipolytic action of insulin
10. Purification of cGMP-binding protein phosphodiesterase from rat lung
11. Platelet cGMP-binding phosphodiesterase
12. Cyclic GMP-binding cyclic GMP-specific phosphodiesterase from lung
13. ANF elicits phosphorylation of the cGMP phosphodiesterase in vascular smooth muscle cells
14. Sildenafil, a novel effective oral therapy for male erectile dysfunction
15. Effect of sildenafil, a type-5 cGMP phosphodiesterase inhibitor, and papaverine on cyclic GMP and cyclic AMP levels in the rabbit corpus cavernosum in vitro
16. Activities of 3′: 5′ cyclic nucleotide phosphodiesterases in the superior cervical ganglion of rat: Characterization, compartmentalization and observations in young and old animals
17. Expression of rat cGMP-binding cGMP-specific phosphodiesterase mRNA in Purkinje cell layers during postnatal neuronal development
18. Isolation and characterization of cDNAs encoding PDE5A, a human cGMP-binding cGMP-specific 3′,5′-cyclic nucleotide phosphodiesterase
19. Inhibition of cGMP breakdown promotes the induction of cerebellar long-term depression
20. A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression
21. Characterization of a purified bovine lung cGMP-binding cGMP phosphodiesterase
22. Cyclic GMP phosphodiesterase-5: Target of sildenafil
23. Substrate- and kinase-directed regulation of phosphorylation of a cGMP-binding phosphodiesterase by cGMP
24. Binding of cGMP to both allosteric sites of cGMP-binding cGMP-specific phosphodiesterase (PDE) is required for its phosphorylation
25. The catalytic subunit of protein kinase A triggers activation of the type V cyclic GMP-specific phosphodiesterase from guinea-pig lung
26. Phosphorylation of phosphodiesterase-5 by cyclic nucleotide-dependent protein kinase alters its catalytic and allosteric cGMP-binding activities
27. The regulation of the cGMP-binding cGMP phosphodiesterase by proteins that are immunologically related to gamma subunit of the gamma subunit of the photoreceptor cGMP phosphodiesterase
28. Induction of cyclic AMP and cyclic GMP 3′: 5′-cyclic nucleotide phosphodiesterase activities in neuroblastoma lines under differentiating conditions
29. cAMP-dependent induction of PDE5 expression in murine neuroblastoma cell differentiation
30. A rapid and sensitive method for the quantitation of microgram quantities of protein
31. Purification and properties of calmodulin-stimulated phosphodiesterase from mammalian brain
32. Purification and characterization of cyclic GMP-stimulated cyclic nucleotide phosphodiesterase from calf liver
33. Isolation and characterization of cGMP phosphodiesterase from bovine rod outer segments
34. Multiple cyclic nucleotide phosphodiesterase activities from rat brain
35. The structure of a bovine lung cGMP-binding, cGMP-specific phosphodiesterase deduced from a cDNA clone
36. Characterization of 3′: 5′ cyclic nucleotide phosphodiesterase activities of mouse neuroblastoma N18TG2 cells
37. 2+-independent adenosine 3′,5′-(cyclic)monophosphate phosphodiesterase in C6 glioma cells
38. Novel alternative splice variants of cGMP-binding cGMP-specific phosphodiesterase
39. Molecular cloning and expression of human cGMP-binding cGMP-specific phosphodiesterase (PDE5)
40. Expression, structure and chromosomal localization of the human cGMP-binding cGMP-specific phosphodiesterase PDE5A gene